A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)
- Resource Type
- Article
- Source
- In
European Journal of Cancer November 2023 193 - Subject
MSC - Language
- ISSN
- 0959-8049